These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6940030)

  • 1. Rubella immunisation.
    St George I
    N Z Med J; 1981 Jan; 93(676):58. PubMed ID: 6940030
    [No Abstract]   [Full Text] [Related]  

  • 2. Rubella immunisation rates in Dundee.
    Hill A
    Health Bull (Edinb); 1986 Sep; 44(5):290-3. PubMed ID: 3781844
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective rubella vaccination programmes: a survey of districts in England and Wales.
    Gay NJ; Valambia S; Galasko D; Miller E
    Commun Dis Rep CDR Rev; 1994 Jun; 4(7):R77-9. PubMed ID: 7520802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Sri Lanka reconsider its rubella immunisation strategy?
    Gunasekara PC; Gunasekera DP
    Ceylon Med J; 1997 Jun; 42(2):64-6. PubMed ID: 9257462
    [No Abstract]   [Full Text] [Related]  

  • 6. Exposure of Ugandan health personnel to measles and rubella: evidence of the need for health worker vaccination.
    Lewis RF; Braka F; Mbabazi W; Makumbi I; Kasasa S; Nanyunja M
    Vaccine; 2006 Nov; 24(47-48):6924-9. PubMed ID: 17014938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against rubella].
    Rudnicka H
    Przegl Epidemiol; 1981; 35(3):403-5. PubMed ID: 7330253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rubella vaccine coverage and seroprotection in 11-year-old children in the Indre-et-Loire department].
    Bourderioux C; Hubert B; Vol S; Feyt M; Drucker J; Tichet J
    Arch Pediatr; 1994 Oct; 1(10):941-3. PubMed ID: 7842078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the immunological status of a sample of the female population 3 years after vaccination against rubella].
    Becchi A; Fornero M
    Nuovi Ann Ig Microbiol; 1981; 32(4):247-52. PubMed ID: 7346775
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program.
    Birnbaum AD; Tessler HH; Schultz KL; Farber MD; Gao W; Lin P; Oh F; Goldstein DA
    Am J Ophthalmol; 2007 Sep; 144(3):424-428. PubMed ID: 17631266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade?
    Coulombe L; Rosser WW
    Can Med Assoc J; 1981 Jul; 125(1):37-40. PubMed ID: 7260807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella immunisation: improving the uptake.
    Carter H; Jones IG
    Health Bull (Edinb); 1988 May; 46(3):182-4. PubMed ID: 3182260
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE; Cutts FT; Samuel R; Diaz-Ortega JL
    Bull World Health Organ; 1997; 75(1):69-80. PubMed ID: 9141752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.